Efficiency of exogenous surfactant combined with intravenous N-acetylcysteine in two-hit rodent model of ARDS

[1]  Yongqing Hou,et al.  N-Acetylcysteine Administration Improves the Redox and Functional Gene Expression Levels in Spleen, Mesenteric Lymph Node and Gastrocnemius Muscle in Piglets Infected with Porcine Epidemic Diarrhea Virus , 2023, Animals : an open access journal from MDPI.

[2]  A. Calkovska,et al.  Efficacy of surfactant therapy of ARDS induced by hydrochloric acid aspiration followed by ventilator-induced lung injury - an animal study. , 2022, Physiological research.

[3]  L. Ware,et al.  Acute Respiratory Distress Syndrome 2022 1 Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes , 2022 .

[4]  A. Calkovska,et al.  N-Acetylcysteine in Mechanically Ventilated Rats with Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome: The Effect of Intravenous Dose on Oxidative Damage and Inflammation , 2021, Biomedicines.

[5]  F. A. Moura,et al.  N-Acetylcysteine (NAC): Impacts on Human Health. , 2021, Antioxidants.

[6]  B. Padhy,et al.  Therapeutic potential of N-acetyl cysteine (NAC) in preventing cytokine storm in COVID-19: review of current evidence. , 2021, European review for medical and pharmacological sciences.

[7]  S. Ohshimo.  Oxygen administration for patients with ARDS , 2021, Journal of Intensive Care.

[8]  M. Kollef,et al.  Pulmonary infections complicating ARDS , 2020, Intensive Care Medicine.

[9]  A. Calkovska,et al.  The Effect of Modified Porcine Surfactant Alone or in Combination with Polymyxin B on Lung Homeostasis in LPS-Challenged and Mechanically Ventilated Adult Rats , 2020, Molecules.

[10]  R. Lauche,et al.  Rapid review of Systematic reviews on the efficacy and safety of Vitamin C in the management of Acute Respiratory Infection and Disease Authors , 2020, Advances in Integrative Medicine.

[11]  Shengwei Jin,et al.  PCTR1 improves pulmonary edema fluid clearance through activating the sodium channel and lymphatic drainage in lipopolysaccharide‐induced ARDS , 2020, Journal of cellular physiology.

[12]  P. Spieth,et al.  Molecular Dynamics of Lipopolysaccharide-Induced Lung Injury in Rodents , 2020, Frontiers in Physiology.

[13]  P. Rodriguez,et al.  Automatic detection of reverse-triggering related asynchronies during mechanical ventilation in ARDS patients using flow and pressure signals , 2019, Journal of Clinical Monitoring and Computing.

[14]  J. Johansson,et al.  Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits , 2019, Respiratory Research.

[15]  Haiyan Zhang.  The effectiveness of N-acetylcysteine for an adult case of pulmonary alveolar proteinosis: A case report , 2019, Respiratory medicine case reports.

[16]  A. Calkovska,et al.  Recombinant Human Superoxide Dismutase and N-Acetylcysteine Addition to Exogenous Surfactant in the Treatment of Meconium Aspiration Syndrome , 2019, Molecules.

[17]  S. Meng,et al.  Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials , 2019, BMC Pulmonary Medicine.

[18]  Mengting Qin,et al.  Changes in TNF-α, IL-6, IL-10 and VEGF in rats with ARDS and the effects of dexamethasone , 2018, Experimental and therapeutic medicine.

[19]  Dao-xin Wang,et al.  Lycium barbarum polysaccharide protects against LPS-induced ARDS by inhibiting apoptosis, oxidative stress, and inflammation in pulmonary endothelial cells , 2018, Free radical research.

[20]  Daniel Brodie,et al.  Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment , 2018, JAMA.

[21]  A. Calkovska,et al.  Pulmonary surfactant and bacterial lipopolysaccharide: the interaction and its functional consequences. , 2017, Physiological research.

[22]  Chengshui Chen,et al.  Lipopolysaccharide-induced CCN1 production enhances interleukin-6 secretion in bronchial epithelial cells , 2017, Cell Biology and Toxicology.

[23]  Yuan Zhang,et al.  Effect of Heme Oxygenase-1 on Mitofusin-1 protein in LPS-induced ALI/ARDS in rats , 2016, Scientific Reports.

[24]  Xiaozhi Wang,et al.  Ulinastatin attenuates pulmonary endothelial glycocalyx damage and inhibits endothelial heparanase activity in LPS-induced ARDS. , 2016, Biochemical and biophysical research communications.

[25]  M. Valvano,et al.  Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. , 2016, FEMS microbiology reviews.

[26]  A. Calkovska,et al.  Effects of surfactant/budesonide therapy on oxidative modifications in the lung in experimental meconium-induced lung injury. , 2016, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[27]  M. Conaway,et al.  The Adult Calfactant in Acute Respiratory Distress Syndrome Trial. , 2015, Chest.

[28]  R. Vieira,et al.  Low level laser therapy reduces acute lung inflammation in a model of pulmonary and extrapulmonary LPS-induced ARDS. , 2014, Journal of photochemistry and photobiology. B, Biology.

[29]  S. Herold,et al.  Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[30]  M. Grocott,et al.  Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome - where do we go from here? , 2012, Critical Care.

[31]  P. Auquier,et al.  Ventilator-associated pneumonia and ICU mortality in severe ARDS patients ventilated according to a lung-protective strategy , 2012, Critical Care.

[32]  Arthur S Slutsky,et al.  An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. , 2011, American journal of respiratory cell and molecular biology.

[33]  Jie Fan,et al.  Association of Toll-Like Receptor Signaling and Reactive Oxygen Species: A Potential Therapeutic Target for Posttrauma Acute Lung Injury , 2010, Mediators of inflammation.

[34]  Abdelwahab Omri,et al.  Effectiveness of liposomal-N-acetylcysteine against LPS-induced lung injuries in rodents. , 2008, International journal of pharmaceutics.

[35]  T. Martin,et al.  Animal models of acute lung injury , 2008, American journal of physiology. Lung cellular and molecular physiology.

[36]  E. Miller,et al.  Hyperoxia-induced signal transduction pathways in pulmonary epithelial cells. , 2007, Free radical biology & medicine.

[37]  M. Andrades,et al.  Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat* , 2006, Critical care medicine.

[38]  R. Veldhuizen,et al.  Hyperoxia exposure impairs surfactant function and metabolism , 2004, Critical care medicine.

[39]  B. Robertson,et al.  Aerosolized surfactant in lung‐lavaged adult rats: factors influencing the therapeutic response , 2000, Acta anaesthesiologica Scandinavica.

[40]  S. Sharar,et al.  The role of leukocyte emigration and IL-8 on the development of lipopolysaccharide-induced lung injury in rabbits. , 1998, Journal of immunology.

[41]  H. Haagsman,et al.  Efficacy of Curosurf in a rat model of acute respiratory distress syndrome. , 1998, The European respiratory journal.

[42]  A. Nathens,et al.  N‐ACETYL CYSTEINE ATTENUATES ACUTE LUNG INJURY IN THE RAT , 1995, Shock.

[43]  F. Stentz,et al.  Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. , 1995, Chest.

[44]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[45]  L. Frank,et al.  The lung and oxygen toxicity. , 1979, Archives of internal medicine.

[46]  J. Lewis,et al.  Effects of ventilation strategies on the efficacy of exogenous surfactant therapy in a rabbit model of acute lung injury. , 1998, American journal of respiratory and critical care medicine.

[47]  M. Takeya,et al.  Histopathologic pulmonary changes from mechanical ventilation at high peak airway pressures. , 1991, The American review of respiratory disease.